✦ LIBER ✦

Molecular docking of enzyme inhibitors : A COMPUTATIONAL TOOL FOR STRUCTURE-BASED DRUG DESIGN

✍ Scribed by Aleksandra Rudnitskaya; Béla Török; Marianna Török

Publisher: The American Society for Biochemistry and Molecular Biology
Year: 2010
Tongue: English
Weight: 175 KB
Volume: 38
Category: Article
ISSN: 1470-8175
DOI: 10.1002/bmb.20392

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification and Mapping of Small-Mole

Identification and Mapping of Small-Molecule Binding Sites in Proteins: Computational Tools for Structure-Based Drug Design.

✍ Christoph Sotriffer; Gerhard Klebe 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB

How Reliable Are Current Docking Approac

How Reliable Are Current Docking Approaches for Structure-Based Drug Design? Lessons from Aldose Reductase

✍ Matthias Zentgraf; Holger Steuber; Cornelia Koch; Concettina La Motta; Stefania 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB 👁 1 views

A Possible Improvement for Structure-Bas

A Possible Improvement for Structure-Based Drug Design Illustrated by the Discovery of a Tat HIV-1 Inhibitor.

✍ Jacques Lebreton; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 165 KB

ChemInform Abstract: Design and Synthesi

ChemInform Abstract: Design and Synthesis of Benzoic Acid Derivatives as Influenza Neuraminidase Inhibitors Using Structure-Based Drug Design.

✍ D. A. WALSH; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 30 KB 👁 1 views

Specificity in structure-based drug desi

Specificity in structure-based drug design: Identification of a novel, selective inhibitor of Pneumocystis carinii dihydrofolate reductase

✍ Daniel A. Gschwend; Worachart Sirawaraporn; Daniel V. Santi; Irwin D. Kuntz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

Specificity is an important aspect of structure-based drug design. Distinguishing between related targets in different organisms is often the key to therapeutic success. Pneumocystis carinii is a fungal opportunist which causes a crippling pneumonia in immunocompromised individuals. We report the id

Peptide design of a competitive inhibito

Peptide design of a competitive inhibitor for HMG-CoA reductase based on statin structure

✍ Valeriy V. Pak; Sung Hee Kim; Minseon Koo; Nari Lee; K. M. Shakhidoyatov; Dae Yo 📂 Article 📅 2006 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 269 KB 👁 1 views

## Abstract This study investigates a proposed design of a peptide sequence that is based on a bioactive conformation of statins that act as the competitive inhibitors of HMG–CoA for HMGR. To bridge these heterogeneous organic compounds, a conformational aspect relating to an analysis of the flexib